Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination High Dose Melphalan and Autologous PBSC Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

NCT00793650 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00793650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination High Dose Melphalan and Autologous PBSC Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Terminated
Start date
May 31, 2005
Completion date
September 30, 2011
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, multiple myeloma